Skibo: Careful Assessment of Supply Chain Risks Could Prevent Shortages
This article was originally published in The Gold Sheet
Executive Summary
Supply chain risk assessments could go a long way toward protecting network resilience from thoughtless cost-cutting that leads to drug shortages, Medimmune VP Andy Skibo tells ISPE cGMP meeting.